FIELD: chemical- -pharmaceutical industry, drugs for injection. SUBSTANCE: aerosol composition has a fluidized hydrofluoroalkane, powder-like drug dispersed in it and polymer that is soluble in indicated hydrofluoroalkane. Polymer has the repeated structural units that are alkyl-containing units and units containing carboxylic acid ester. Invention provides making an ecologically pure aerosol composition, necessary pressure, good solubility and stabilization of drugs. EFFECT: improved quality of aerosol composition. 19 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE AND METHOD FOR INHALATION | 1996 |
|
RU2137510C1 |
| PHARMACEUTICAL AEROSOL COMPOSITION | 2009 |
|
RU2565438C2 |
| METHOD FOR PREPARATION OF CALCIUM SALT OF 10-PROPYL-2,8-BIS-(1H-TETRAZOLE-5-YL) | 0 |
|
SU1641192A3 |
| TROVENTOL-BASED COMPOSITION | 2006 |
|
RU2457832C2 |
| 4-AMINOPHENOL DERIVATIVES OR THEIR N-ALKYL OR SALT DERIVATIVES SHOWING ANTIINFLAMMATORY ACTIVITY | 1990 |
|
RU2049779C1 |
| DERIVATIVES OF 1,3,4-THIADIAZOLE-2-CARBOXYLIC ACIDS | 1992 |
|
RU2050357C1 |
| METHOD OF OBTAINING SULFINYL THIONYL DERIVATIVES OF HETEROGENEOUS RING COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 0 |
|
SU1524807A3 |
| PROTEIN STABILISATION FORMULATION FREE FROM MAMMALIAN EXCIPIENTS | 2010 |
|
RU2539388C2 |
| PROLONGED-RELEASE ORAL PHARMACEUTICAL MEDICINAL FORM | 1998 |
|
RU2214232C2 |
| MEDICAMENTS | 1995 |
|
RU2157188C2 |
